HOMEOPATHIC ACIDUM RIBONUCLEICUM IN THE TREATMENT OF CHRONIC AND DEGENERATIVE DISEASES: FOUNDATIONS, MATERIA MEDICA, AND CLINICAL APPLICATIONS
INTERNATIONAL BLEST SCIENTIFIC · 2026
DOI: 10.65671/9fkbfy21 ↗Kurz gefasst
Fachartikel in der Zeitschrift INTERNATIONAL BLEST SCIENTIFIC, 2026. Verfasst von Luiz Stern.
Abstract (Originalsprache)
Chronic and degenerative diseases frequently involve persistent fatigue, cognitive impairment, reduced functional reserve, and incomplete recovery, clinical dimensions that may overlap with the symptom profile attributed to homeopathic Acidum Ribonucleicum. This study critically analyzed its historical and pathogenetic foundations, materia medica, clinical profile, differential diagnosis, therapeutic applications, and potential interfaces with contemporary RNA biology. A critical narrative review was conducted using a predefined corpus of 25 references encompassing sources specifically addressing Acidum Ribonucleicum, homeopathic pathogenetic trials and methodological foundations, experimental studies of highly diluted systems, and biomedical literature on RNA, extracellular vesicles, mitochondrial dysfunction, cellular senescence, and aging. The analysis identified a multidimensional symptom pattern characterized predominantly by the convergence of physical and mental exhaustion, impaired memory and concentration, sleep-related disturbances, and insufficient recovery. This configuration supported the concept of “restoration failure” as an integrative clinical construct for organizing the materia medica, rather than as an established pathophysiological mechanism. The available documentation was more consistent for pathogenetic characterization than for disease-specific therapeutic applications, standardized potency regimens, or reproducible clinical outcomes. Experimental evidence concerning nanoparticles, gene expression, and biological responses to highly diluted preparations, together with contemporary knowledge of RNA-mediated regulation, mitochondrial function, extracellular communication, and senescence, provides a framework for generating testable hypotheses but does not establish a specific mechanism of action for Acidum Ribonucleicum. The findings therefore delineate a clinically structured yet scientifically underexplored field in which pathogenetic reproducibility, prospective clinical documentation, physicochemical characterization, and molecular investigation remain priorities. Acidum Ribonucleicum should consequently be regarded as a candidate for systematic investigation based on individualized symptom correspondence, while claims of disease-specific efficacy or molecular mechanisms require direct, controlled, and reproducible experimental confirmation.
Zitieren
APA
Stern, L. (2026). HOMEOPATHIC ACIDUM RIBONUCLEICUM IN THE TREATMENT OF CHRONIC AND DEGENERATIVE DISEASES: FOUNDATIONS, MATERIA MEDICA, AND CLINICAL APPLICATIONS. INTERNATIONAL BLEST SCIENTIFIC. https://doi.org/10.65671/9fkbfy21
Vancouver
Stern L. HOMEOPATHIC ACIDUM RIBONUCLEICUM IN THE TREATMENT OF CHRONIC AND DEGENERATIVE DISEASES: FOUNDATIONS, MATERIA MEDICA, AND CLINICAL APPLICATIONS. INTERNATIONAL BLEST SCIENTIFIC. 2026. doi:10.65671/9fkbfy21
BibTeX
@article{Stern2026,
author = {Stern, Luiz},
title = {HOMEOPATHIC ACIDUM RIBONUCLEICUM IN THE TREATMENT OF CHRONIC AND DEGENERATIVE DISEASES: FOUNDATIONS, MATERIA MEDICA, AND CLINICAL APPLICATIONS},
journal = {INTERNATIONAL BLEST SCIENTIFIC},
year = {2026},
doi = {10.65671/9fkbfy21}
}
EUVIMED